FBIOP

49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

Fortress Biotech Announces Positive Opinion on Orphan Drug Designation Received from the European Medicines Agency for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease

Fortress Biotech Announces Publication of Study on Targeted Next Generation Sequencing for Newborn Screening of Menkes Disease in Molecular Genetics and Metabolism Reports

Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results

Fortress Biotech, Inc.'s (NASDAQ:FBIO) Path To Profitability

Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)